BioPartners supports cardiovascular research involving diagnostic validation, device performance studies, biomarker development, therapeutic evaluations, and observational programs.

We work with sponsors developing assays for cardiac biomarkers (e.g., troponins, BNP/NT-proBNP, D-dimer), vascular inflammation markers, lipid panels, and emerging precision cardiology biomarkers.

Our clinical teams follow standardized measurement procedures to ensure the accuracy and consistency of cardiovascular data. We manage detailed clinical information including symptom history, risk profiles, medical background, imaging results (if provided), and medication use.

Sample types may include plasma, serum, whole blood, urine, and additional specialized matrices as needed. Our controlled workflows ensure high biospecimen integrity and reproducibility — critical for cardiovascular innovation.

BioPartners’ network provides access to diverse patient populations, supporting studies involving acute presentations, chronic cardiovascular conditions, and population-level screening programs.

Quality, consistency, and reliability define our cardiovascular research capabilities.